| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of CRYBG1 mRNA | 19933214 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CRYBG1 mRNA | 21420995 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CRYBG1 mRNA | 17562736 |
| D020106 | Acrylamide | Acrylamide results in increased expression of CRYBG1 mRNA | 28959563 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of CRYBG1 mRNA | 27153756 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of CRYBG1 gene | 27153756 |
| C430898 | AGN 194204 | AGN 194204 results in decreased expression of CRYBG1 mRNA | 16339527 |
| D000447 | Aldehydes | Aldehydes results in increased expression of CRYBG1 mRNA | 25014914 |
| C487081 | belinostat | belinostat results in increased expression of CRYBG1 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| D001554 | Benzene | Benzene results in increased expression of CRYBG1 mRNA | 19162166 |
| D001564 | Benzo(a)pyrene | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CRYBG1 mRNA] | 22228805 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CRYBG1 mRNA | 21569818|2261060 |
| D004958 | Estradiol | Estradiol results in decreased expression of CRYBG1 mRNA | 21185374 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of CRYBG1 mRNA | 25181051 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of CRYBG1 mRNA | 26079696 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CRYBG1 mRNA | 26472689 |
| D002857 | Chromium | Chromium results in decreased expression of CRYBG1 mRNA | 21437242 |
| D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of CRYBG1 mRNA | 19549813 |
| C030973 | cupric oxide | cupric oxide results in increased expression of CRYBG1 protein | 25470785 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of CRYBG1 mRNA | 25562108 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of CRYBG1 mRNA | 27989131 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of CRYBG1 mRNA | 12782123 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of CRYBG1 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of CRYBG1 mRNA | 27392435 |
| C118739 | entinostat | entinostat results in increased expression of CRYBG1 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| D004397 | Fonofos | Fonofos results in increased methylation of CRYBG1 promoter | 22847954 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of CRYBG1 mRNA | 28973697 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of CRYBG1 mRNA | 20044591 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CRYBG1 mRNA | 25613284 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of CRYBG1 mRNA | 27392435 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CRYBG1 mRNA | 24796395 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon affects the expression of CRYBG1 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of CRYBG1 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of CRYBG1 mRNA" | 25620056 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of CRYBG1 mRNA | 26272509 |
| D010278 | Parathion | Parathion results in increased methylation of CRYBG1 promoter | 22847954 |
| C046012 | pentanal | pentanal results in increased expression of CRYBG1 mRNA | 26079696 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of CRYBG1 mRNA | 18445702|2381119 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CRYBG1 mRNA | 23557933 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of CRYBG1 mRNA | 22714537 |
| C005556 | propionaldehyde | propionaldehyde results in increased expression of CRYBG1 mRNA | 26079696 |
| D011794 | Quercetin | Quercetin results in decreased expression of CRYBG1 mRNA | 21632981 |
| C012568 | terbufos | terbufos results in increased methylation of CRYBG1 promoter | 22847954 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A results in decreased expression of CRYBG1 mRNA | 25172293 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CRYBG1 mRNA | 20106945|2163298 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CRYBG1 mRNA | 18691609|1977048 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CRYBG1 mRNA | 25613284 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of CRYBG1 mRNA | 23557971 |
| D019772 | Topotecan | CRYBG1 protein affects the susceptibility to Topotecan | 16217747 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CRYBG1 mRNA | 21934132 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CRYBG1 mRNA | 24935251 |
| C057693 | troglitazone | troglitazone results in decreased expression of CRYBG1 mRNA | 28973697 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRYBG1 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of CRYBG1 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of CRYBG1 mRNA | 19101580|2317975 |